|
|
||||||
|
|
||||||
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Prepared by: |
Rebecca Nicks |
|
|
Date: |
November 2007 |
|
|
Review Date: |
November 2009 |
|
|
Clinical Question: |
What is the most valid, reliable and sensitive measure for use by occupational therapists working in acute care settings to assess cognitive impairments that are likely to affect occupational performance in adults following an acquired brain impairment? |
|
|
Clinical Scenario: |
Following acquired brain impairment people may experience cognitive impairment that can impact on their functioning and occupational performance. Occupational therapists’ working in acute hospitals are required to quickly conduct assessments, formulate discharge plans and make recommendations regarding a persons occupational performance. The author wanted to investigate a tool that occupational therapists working in the acute hospital setting can use to assess cognition of people following acquired brain impairment. |
|
|
Clinical Bottom Line: |
The Cognistat is a sensitive measure of cognition that is quick to administer and enables therapists working in acute hospitals to screen people for cognitive deficits following acquired brain impairment. However, it cannot be used to accurately generate information regarding specific cognitive impairments. |
| BB | |
Full Document: |
|
File Size: |
79Kb |
|
|
Supported by the University of Western Sydney
|
 |
 |
Click
to download PDF